Development of a Zika vaccine

Expert Review of Vaccines

Volumn 15, Issue 9, 2016, Pages 1083-1085

  Tripp, Ralph A ^a   Ross, Ted M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

countermeasures; immunity; vaccine; virus; Zika

Indexed keywords

ZIKA VIRUS VACCINE; VIRUS VACCINE;

DRUG EFFICACY; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; ZIKA FEVER; ZIKA VIRUS; ANIMAL; DRUG APPROVAL; DRUG DEVELOPMENT; IMMUNOLOGY; PATHOGENICITY; PROCEDURES; TRANSMISSION;

ANIMALS; DRUG APPROVAL; DRUG DISCOVERY; HUMANS; VIRAL VACCINES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84976273968     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1080/14760584.2016.1192474     Document Type: Editorial

References (20)

1. G.W.Dick, S.F.Kitchen, A.J.Haddow Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46:509–520.• One of the earliest papers describing zika virus in Africa.
2. C.L.Keighley, R.B.Saunderson, J.Kok, et al. Viral exanthems. Curr Opin Infect Dis. 2015;28:139–150. doi:10.1097/QCO.0000000000000145.
3. D.Gatherer, A.Kohl. Zika virus:a previously slow pandemic spreads rapidly through the Americas. J Gen Virol. 2016;97:269–273. doi:10.1099/jgv.0.000381.
4. C.B.Marcondes, M.F.Ximenes. Zika virus in Brazil and the danger of infestation by Aedes (Stegomyia) mosquitoes. Revista da Sociedade Brasileira de Medicina Tropical. 2015. doi:10.1590/0037-8682-0220-2015.•• Comprehensive review of zika virus infections in Brazil in 2015.
5. E.J.Rubin, M.F.Greene, L.R.Baden. Zika virus and microcephaly. N Engl J Med. 2016;374:984–985. doi:10.1056/NEJMe1601862.•• Descriptions of zika virus and microcephaly in the Americas.
6. E.E.Petersen, J.E.Staples, D.Meaney-Delman, et al. Interim guidelines for pregnant women during a Zika virus outbreak - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:30–33. doi:10.15585/mmwr.mm6502e1.
7. S.L.Hills, K.Russell, M.Hennessey, et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission - continental United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:215–216. doi:10.15585/mmwr.mm6508e2.
8. D.W.Smith, J.Mackenzie. Zika virus and Guillain-Barre syndrome:another viral cause to add to the list. Lancet. 2016;387:1486–1488. doi:10.1016/S0140-6736(16)00564-X.
9. E.B.Hayes. Zika virus outside Africa. Emerg Infect Dis. 2009;15:1347–1350. doi:10.3201/eid1509.090442.
10. O.Faye, C.C.M.Freire, A.Iamarino, et al. Molecular evolution of Zika virus during its emergence in the 20th century. PLoS Negl Trop Dis. 2014;8:e2636. doi:10.1371/journal.pntd.0002636.• Overview of the molecular evolution of zika virus for the last 70 years.
11. A.D.Haddow, A.J.Schuh, C.Y.Yasuda, et al. Genetic characterization of Zika virus strains:geographic expansion of the Asian lineage. PLoS Negl Trop Dis. 2012;6:e1477. doi:10.1371/journal.pntd.0001477.
12. N.D.Wolfe, A.M.Kilbourn, W.B.Karesh, et al. Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med Hyg. 2001;64:310–316.
13. J.F.Chan, G.K.Choi, C.C.Yip, et al. Zika fever and congenital Zika syndrome:an unexpected emerging arboviral disease? J Infect. 2016;72:507–524. doi:10.1016/j.jinf.2016.02.011.
14. O.Faye, O.Faye, D.Diallo, et al. Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes. Virol J. 2013;10:311. doi:10.1186/1743-422X-10-311.
15. M.G.Guzman, S.B.Halstead, H.Artsob, et al. Dengue:a continuing global threat. Nat Rev Microbiol. 2010;8:S7–16. doi:10.1038/nrmicro2460.
16. S.L.Rossi, F.Nasar, J.Cardosa, et al. Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology. 2012;423:58–67. doi:10.1016/j.virol.2011.11.018.
17. D.R.Lucey, L.O.Gostin. The emerging Zika pandemic:enhancing preparedness. JAMA. 2016;315:865–866. doi:10.1001/jama.2016.0904.
18. C.Chang, K.Ortiz, A.Ansari, et al. The Zika outbreak of the 21st century. J Autoimmun. 2016;68:1–13. doi:10.1016/j.jaut.2016.02.006.
19. A.P.Durbin, B.D.Kirkpatrick, K.K.Pierce, et al. A 12-month interval dosing study in adults indicates that a single dose of the NIAID tetravalent dengue vaccine induces a robust neutralizing antibody response. J Infect Dis. 2016. doi:10.1093/infdis/jiw067.
20. S.J.Thomas, T.P.Endy. Critical issues in dengue vaccine development. Curr Opin Infect Dis. 2011;24:442–450. doi:10.1097/QCO.0b013e32834a1b0b.